C6 Biotin Ceramide (d18:1/6:0)
- CAS No.
- 192070-02-3
- Chemical Name:
- C6 Biotin Ceramide (d18:1/6:0)
- Synonyms
- C6 Biotin Ceramide (d18:1/6:0);N-Hexanoyl-biotin-D-erythro-sphingosine;(3aS,4S,6aR)-hexahydro-N-[6-[[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]amino]-6-oxohexyl]-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide;1H-Thieno[3,4-d]imidazole-4-pentanamide, hexahydro-N-[6-[[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]amino]-6-oxohexyl]-2-oxo-, (3aS,4S,6aR)-
- CBNumber:
- CB24665612
- Molecular Formula:
- C34H62N4O5S
- Molecular Weight:
- 638.94
- MDL Number:
- MFCD19705498
- MOL File:
- 192070-02-3.mol
C6 Biotin Ceramide (d18:1/6:0) price More Price(1)
C6 Biotin Ceramide (d18:1/6:0) Chemical Properties,Uses,Production
Description
C6 Ceramide-biotin is an affinity probe that allows C2 ceramide (d18:1/2:0) to be detected or immobilized through interaction with the biotin ligand. C6 Ceramide-biotin has been used to detect ceramide binding partners, such as inhibitor 2 of protein phosphatase 2A (I2PP2A), in vitro and in situ.1 C6 ceramide is a cell-permeable analog of naturally occurring ceramides. With a longer carbon chain than C2 ceramide , it is somewhat more hydrophobic and may more closely mimic the effects of natural ceramides.2 C6 ceramide mediates many diverse biological activities including apoptosis, activation of PP2A, and inhibition of the mitochondrial respiratory chain.2,3,4,5 It also enhances the expression of COX-2 in rat granulosa cells and stimulates the growth of bovine aortic smooth muscle cells.6,7 C6 ceramide acts in neuronal axons to inhibit neurite growth.8
Uses
C6 Biotin ceramide (d18:1/6:0) is a biochemical reagent.
References
1. Mukhopadhyay, A., Saddoughi, S.A., Song, P., et al. Direct interaction between the inhibitor 2 and ceramide via sphingolipid-
2. Dobrowsky, R.T., and Hannun, Y.A. Ceramide stimulates a cytosolic protein phosphatase J. Biol. Chem. 267(8),5048-5051(1992).
3. Cai, Z., Bettaieb, A., El Mahdani, N., et al. Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-
4. Dobrowsky, R.T., Kamibayashi, C., Mumby, M.C., et al. Ceramide activates heterotrimeric protein phosphatase 2A J. Biol. Chem. 268(21),15523-15530(1993).
5. Gudz, T.I., Tserng, K.Y., and Hoppel, C.L. Direct inhibition of mitochondrial respiratory chain complex III by cell-
6. Santana, P., Llanes, L., Hernandez, I., et al. Interleukin-
7. Augé, N., Andrieu, N., Nègre-Salvayre, A., et al. The sphingomyelin-
8. Posse de Chaves, E.I., Bussière, M., Vance, D.E., et al. Elevation of ceramide within distal neurites inhibits neurite growth in cultured rat sympathetic neurons J. Biol. Chem. 272(4),2038-3035(1997).
C6 Biotin Ceramide (d18:1/6:0) Preparation Products And Raw materials
Raw materials
Preparation Products
C6 Biotin Ceramide (d18:1/6:0) Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Shanghai Hongye Biotechnology Co. Ltd | 400-9205774 | sales@glpbio.cn | China | 6777 | 58 |
MedBioPharmaceutical Technology Inc | 021-69568360 18916172912 | order@med-bio.cn | China | 8140 | 58 |
ChemeGen 中國 | 18818260767 | 2625930290@qq.com | China | 6973 | 58 |
Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 11973 | 58 |
TargetMol Chemicals Inc. | 15002134094 | marketing@targetmol.cn | China | 21356 | 58 |
SHANGHAI ZZBIO CO., LTD. | 15102117276 19921389125 | tech@zzbioco.com | China | 12064 | 58 |
4008-099-669 | 23419001name@qq.com | CHINA | 6043 | 58 | |
Cayman Chemical Company | 800-364-9897 | sales@caymanchem.com | China | 6838 | 58 |
Enzo Biochem Inc | Enzo Biochem Inc. 13797054060 | Enzoname@qq.com | China | 6174 | 58 |
Supplier | Advantage |
---|---|
Shanghai Hongye Biotechnology Co. Ltd | 58 |
MedBioPharmaceutical Technology Inc | 58 |
ChemeGen 中國 | 58 |
Shanghai Yifei Biotechnology Co. , Ltd. | 58 |
TargetMol Chemicals Inc. | 58 |
SHANGHAI ZZBIO CO., LTD. | 58 |
58 | |
Cayman Chemical Company | 58 |
Enzo Biochem Inc | 58 |